Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.52% is 52% below its 5-year average of 7.29%, near the low end of its 5-year range (3.52%–10.75%).
As of the fiscal period ended Tuesday, June 30, 2026. 23.73% below its 12-month average of 4.61%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.52%.
DEBT TO ASSETS RATIO
3.52%
DEBT TO ASSETS RATIO AVG TTM
4.61%
DEBT TO ASSETS RATIO AVG 3Y
7.44%
DEBT TO ASSETS RATIO AVG 5Y
7.29%
DEBT TO ASSETS RATIO AVG 10Y
5.08%
DEBT TO ASSETS RATIO AVG 15Y
4.13%
DEBT TO ASSETS RATIO AVG 20Y
159.49%
CURRENT VS TTM AVG
-23.73%
CURRENT VS 3Y AVG
-52.74%
CURRENT VS 5Y AVG
-51.77%
CURRENT VS 10Y AVG
-30.74%
CURRENT VS 15Y AVG
-14.76%
CURRENT VS 20Y AVG
-97.79%
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 442 covered companies
CURRENT VS SECTOR MEDIAN
+3097.20%
vs the sector median at left
BioLife Solutions, Inc.
Market Cap
$1.89B
Debt to Assets Ratio
3.52%
TTM Avg
4.61%
3Y Avg
7.44%
5Y Avg
7.29%
Market Cap
$1.87B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.83B
Debt to Assets Ratio
0.43%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.96B
Debt to Assets Ratio
0.75%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.78B
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.78B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioLife Solutions, Inc. (BLFS) | $1.89B | 3.52% | 4.61% | 7.44% | 7.29% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | 0.03% | N/A | N/A | N/A |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 0.43% | N/A | N/A | N/A |
| Absci Corporation (ABSI)vs › | $1.95B | 0.01% | N/A | N/A | N/A |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | 0.75% | N/A | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $1.97B | 0.03% | N/A | N/A | N/A |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | 0.11% | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | 0.09% | N/A | N/A | N/A |
| AxoGen, Inc. (AXGN)vs › | $2.00B | 0.07% | N/A | N/A | N/A |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | 0.41% | N/A | N/A | N/A |
Debt/Assets
3.5%
Debt/Equity
0.04
Current Ratio
9.69
Interest Coverage
-0.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.52% |
| 2026-03-31 | 3.71% |
| 2025-12-31 | 4.41% |
| 2025-09-30 | 5.27% |
| 2025-06-30 | 6.15% |
| 2025-03-31 | 6.82% |
| 2024-12-31 | 7.55% |
| 2024-09-30 | 10.29% |
| 2024-06-30 | 9.59% |
| 2024-03-31 | 10.20% |
| 2023-12-31 | 8.20% |
| 2023-09-30 | 10.75% |
| 2023-06-30 | 10.29% |
| 2023-03-31 | 9.68% |
| 2022-12-31 | 9.71% |
| 2022-09-30 | 9.59% |
| 2022-06-30 | 6.11% |
| 2022-03-31 | 4.78% |
| 2021-12-31 | 4.85% |
| 2021-09-30 | 5.54% |
| 2021-06-30 | 6.12% |
| 2021-03-31 | 5.61% |
| 2020-12-31 | 4.75% |
| 2020-09-30 | 0.39% |
| 2020-06-30 | 0.84% |
| 2020-03-31 | 1.22% |
| 2019-12-31 | 1.47% |
| 2019-09-30 | 1.83% |
| 2019-06-30 | 2.89% |
| 2019-03-31 | 3.45% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 45.79% |
| 2016-12-31 | 35.88% |
| 2016-09-30 | 16.26% |
| 2016-06-30 | 6.23% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2015-01-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 316.20% |
| 2013-09-30 | 330.62% |
| 2013-06-30 | 308.49% |
| 2013-03-31 | 310.10% |
| 2012-12-31 | 334.50% |
| 2012-09-30 | 310.14% |
| 2012-06-30 | 345.40% |
| 2012-03-31 | 551.05% |
| 2011-12-31 | 609.50% |
| 2011-09-30 | 633.04% |
| 2011-06-30 | 655.58% |
| 2011-03-31 | 676.65% |
| 2010-12-31 | 690.05% |
| 2010-09-30 | 675.46% |
| 2010-06-30 | 613.10% |
| 2010-03-31 | 612.80% |
| 2009-12-31 | 591.47% |
| 2009-09-30 | 579.24% |
| 2009-06-30 | 578.60% |
| 2009-03-31 | 370.32% |
| 2008-12-31 | 432.52% |
| 2008-09-30 | 342.63% |
| 2008-06-30 | 465.85% |
| 2008-03-31 | 405.27% |
| 2007-12-31 | 378.78% |
| 2007-09-30 | 185.57% |
| 2007-06-30 | 148.90% |
| 2007-03-31 | 100.39% |
| 2006-12-31 | 35.24% |
| 2006-09-30 | 28.23% |
| 2006-06-30 | 23.69% |
| 2006-03-31 | 75.45% |
| 2005-12-31 | 50.53% |
| 2005-09-30 | 35.75% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 23.80% |
| 2003-09-30 | 216.96% |
| 2003-06-30 | 169.51% |
| 2003-03-31 | 117.35% |
| 2002-12-31 | 110.19% |
| 2002-09-30 | 16.61% |
